MitoQ for Fatigue in Multiple Sclerosis (MS)

Phase 1

Phase 2

MitoQMitoQ for Fatigue in Multiple Sclerosis (MS)

Sponsor:

VA Office of Research and Development

Code:

NCT04267926

Conditions

Multiple Sclerosis

Fatigue

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

20 mg MitoQ

Placebo

40mg of MitoQ

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-16. This information was provided to ClinicalTrials.gov by VA Office of Research and Development on 2025-04-06.